A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma
Esteban J. Rozen(University of Massachusetts Chan Medical School), Jason M. Shohet(University of Massachusetts Chan Medical School)
Cited by 2
Related Papers
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
|Oncotarget|2018|39
A novel druggable DYRK3/CAMKV signaling module for Neuroblastoma tumor growth inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0